Affinity DataKi: 0.910nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 1.10nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 2.20nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 2.40nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 2.90nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 9.10nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 10nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 19nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 23nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 74nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 132nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 155nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 263nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: 407nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataKi: <1.00E+4nMAssay Description:Displacement of [125I]human urotensin-2 from human GPR14 transfected in CHO cellsChecked by AuthorMore data for this Ligand-Target Pair
Affinity DataIC50: 1.30nMAssay Description:Displacement of [125I]26RFa from human GPR103 expressed in HEK293 cells incubated for 1 h by gamma counter based methodMore data for this Ligand-Target Pair
Affinity DataIC50: 579nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.99E+3nMAssay Description:Displacement of [125I]26RFa from human GPR103 expressed in HEK293 cells incubated for 1 h by gamma counter based methodMore data for this Ligand-Target Pair
Affinity DataIC50: 2.99E+3nMAssay Description:Displacement of [125I]26RFa from human GPR103 expressed in HEK293 cells incubated for 1 h by gamma counter based methodMore data for this Ligand-Target Pair
Affinity DataIC50: 6.06E+3nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 8.25E+3nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 8.73E+3nMAssay Description:Displacement of [125I]26RFa from human GPR103 expressed in HEK293 cells incubated for 1 h by gamma counter based methodMore data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracell...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracell...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracell...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+4nMAssay Description:Antagonist activity at human GPR103 expressed in CHO cells co-expressing Galpha16 assessed as inhibition of human 26RFa-induced increase in intracell...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair
Affinity DataIC50: 1.00E+5nMAssay Description:Antagonist activity at human QRFPR expressed in CHO cells co-expressing Galpha16 assessed as inhibition of 26RFa-induced Ca2+ mobilization preincubat...More data for this Ligand-Target Pair